• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Top 20 Lower Middle Market Investment Banks [Q1]

Share:

July 15, 2019

Axial league tables take into account three main characteristics: client quality, buy-side targeting, and process effectiveness (for detailed methodology, see the end of this post).

For CEOs and dealmakers in the lower middle market, these league tables are a useful barometer to measure how an investment bank ranks against its peers, and how effective it is in financing and selling lower middle market businesses in various sectors.

767 investment banks brought deals to market using Axial in Q1.
Here are the top 20.

Top 20 Investment Banks

 

Rank Firm HQ Score
1 Hilliard Lyons KY .99
2 Peakstone Group IL .98
3 Evangeline Securities LA .97
4 Osage Advisors CT .96
5 FourBridges Capital TN .95
6 Tully & Holland MA .95
7 SDR Ventures CO .94
8 RLS Associates DE .94
9 Solganick & Co. CA .93
10 FirePower Capital ON .93
11 Spektrum Capital Advisors PA .93
12 Capello Global CA .93
13 Strategic Finance CO .92
14 Baker Tilly Capital IL .92
15 martinwolf M&A Advisors AZ .92
16 League Park Advisors OH .91
17 Roadmap Advisors VA .91
18 Loop Capital Markets NY .91
19 Allied Millennial Partners NY .91
20 Insight Advisory Partners IL .91

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

 

 

Date: July 15, 2019

Source: AXIAL

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Kinnate Biopharma Inc. Announces Acquisition of Ownership Stake from Series a Investors of the China Joint Venture, Kinnjiu Biopharma Inc., and Initiation of Phase 1 Clinical Trial for Exarafenib (KIN-2787) in People’s Republic of ChinaKinnate Biopharma Inc. Announces Acquisition of Ownership Stake from Series a Investors of the China Joint Venture, Kinnjiu Biopharma Inc., and Initiation of Phase 1 Clinical Trial for Exarafenib (KIN-2787) in People’s Republic of China
  • Takeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 MillionTakeda Acquires Celiac-Focused PvP Biologics in Deal Worth $330 Million
  • Aridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform TechnologyAridis Pharmaceuticals Enters Into Equity Purchase and Option Agreements with The Serum Institute of India, Ltd for Exclusive License to Products and MabIgX® Platform Technology
  • HealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health PartnersHealthLynked Closes Acquisition of Cura Health Management, LLC and ACO Health Partners
  • Wishbone Medical makes acquisitionWishbone Medical makes acquisition
  • Madison Dearborn Partners Completes Acquisition of Benefytt TechnologiesMadison Dearborn Partners Completes Acquisition of Benefytt Technologies
  • UCLA Health’s COVID-19 Swab Shortage Solved With 3D-Printed SwabsUCLA Health’s COVID-19 Swab Shortage Solved With 3D-Printed Swabs
  • Editas, Allergan Open First Trial of In vivo CRISPR TherapyEditas, Allergan Open First Trial of In vivo CRISPR Therapy

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications